102 related articles for article (PubMed ID: 20155394)
1. Brain pathways mediating the pro-aggressive effect of the steroid sulfatase (Sts) gene.
Mortaud S; Nicolas L; Pinoteau W; Tordjman S; Carlier M; Roubertoux PL
Behav Genet; 2010 Mar; 40(2):211-9. PubMed ID: 20155394
[TBL] [Abstract][Full Text] [Related]
2. Aggressive behavior induced by the steroid sulfatase inhibitor COUMATE and by DHEAS in CBA/H mice.
Nicolas LB; Pinoteau W; Papot S; Routier S; Guillaumet G; Mortaud S
Brain Res; 2001 Dec; 922(2):216-22. PubMed ID: 11743952
[TBL] [Abstract][Full Text] [Related]
3. Steroid sulfatase (STS) expression in the human temporal lobe: enzyme activity, mRNA expression and immunohistochemistry study.
Steckelbroeck S; Nassen A; Ugele B; Ludwig M; Watzka M; Reissinger A; Clusmann H; Lütjohann D; Siekmann L; Klingmüller D; Hans VH
J Neurochem; 2004 Apr; 89(2):403-17. PubMed ID: 15056284
[TBL] [Abstract][Full Text] [Related]
4. Role of steroid sulfatase in steroid homeostasis and characterization of the sulfated steroid pathway: Evidence from steroid sulfatase deficiency.
Sánchez-Guijo A; Neunzig J; Gerber A; Oji V; Hartmann MF; Schuppe HC; Traupe H; Bernhardt R; Wudy SA
Mol Cell Endocrinol; 2016 Dec; 437():142-153. PubMed ID: 27531568
[TBL] [Abstract][Full Text] [Related]
5. Tissue-specific transcriptional initiation and activity of steroid sulfatase complementing dehydroepiandrosterone sulfate uptake and intracrine steroid activations in human adipose tissue.
Dalla Valle L; Toffolo V; Nardi A; Fiore C; Bernante P; Di Liddo R; Parnigotto PP; Colombo L
J Endocrinol; 2006 Jul; 190(1):129-39. PubMed ID: 16837617
[TBL] [Abstract][Full Text] [Related]
6. Steroid sulfatase mediated growth Sof human MG-63 pre-osteoblastic cells.
Dias NJ; Selcer KW
Steroids; 2014 Oct; 88():77-82. PubMed ID: 25042472
[TBL] [Abstract][Full Text] [Related]
7. Alleles of the microsomal steroid sulfatase gene (Sts) in the pseudoautosomal region of the heterosomes of the mouse.
Roubertoux PL; Degrelle H; Maxson SC; Phillips J; Tordjman S; Moutier R; Dupertuis-Hass MC
C R Acad Sci III; 1994 Jun; 317(6):523-7. PubMed ID: 7987703
[TBL] [Abstract][Full Text] [Related]
8. Attack behaviors in mice: from factorial structure to quantitative trait loci mapping.
Roubertoux PL; Guillot PV; Mortaud S; Pratte M; Jamon M; Cohen-Salmon C; Tordjman S
Eur J Pharmacol; 2005 Dec; 526(1-3):172-85. PubMed ID: 16266699
[TBL] [Abstract][Full Text] [Related]
9. Steroid sulfatase gene variation and DHEA responsiveness to resistance exercise in MERET.
Riechman SE; Fabian TJ; Kroboth PD; Ferrell RE
Physiol Genomics; 2004 May; 17(3):300-6. PubMed ID: 15152080
[TBL] [Abstract][Full Text] [Related]
10. The steroid sulfatase inhibitor COUMATE attenuates rather than enhances access of dehydroepiandrosterone sulfate to the brain in the mouse.
Nicolas LB; Fry JP
Brain Res; 2007 Oct; 1174():92-6. PubMed ID: 17868658
[TBL] [Abstract][Full Text] [Related]
11. The development of steroid sulfatase inhibitors for hormone-dependent cancer therapy.
Day JM; Purohit A; Tutill HJ; Foster PA; Woo LW; Potter BV; Reed MJ
Ann N Y Acad Sci; 2009 Feb; 1155():80-7. PubMed ID: 19250195
[TBL] [Abstract][Full Text] [Related]
12. Analysis for localization of steroid sulfatase in human tissues.
Suzuki T; Miki Y; Fukuda T; Nakata T; Moriya T; Sasano H
Methods Enzymol; 2005; 400():303-16. PubMed ID: 16399357
[TBL] [Abstract][Full Text] [Related]
13. Effects of mutations and glycosylations on STS activity: a site-directed mutagenesis study.
Stengel C; Newman SP; Day JM; Tutill HJ; Reed MJ; Purohit A
Mol Cell Endocrinol; 2008 Feb; 283(1-2):76-82. PubMed ID: 18180093
[TBL] [Abstract][Full Text] [Related]
14. Expression of steroid sulfatase during embryogenesis.
Compagnone NA; Salido E; Shapiro LJ; Mellon SH
Endocrinology; 1997 Nov; 138(11):4768-73. PubMed ID: 9348204
[TBL] [Abstract][Full Text] [Related]
15. Genetic correlation between steroid sulfatase concentration and initiation of attack behavior in mice.
Le Roy I; Mortaud S; Tordjman S; Donsez-Darcel E; Carlier M; Degrelle H; Roubertoux PL
Behav Genet; 1999 Mar; 29(2):131-6. PubMed ID: 10405462
[TBL] [Abstract][Full Text] [Related]
16. The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer.
Al Sarakbi W; Mokbel R; Salhab M; Jiang WG; Reed MJ; Mokbel K
Anticancer Res; 2006; 26(6C):4985-90. PubMed ID: 17214375
[TBL] [Abstract][Full Text] [Related]
17. In vivo efficacy of STX213, a second-generation steroid sulfatase inhibitor, for hormone-dependent breast cancer therapy.
Foster PA; Newman SP; Chander SK; Stengel C; Jhalli R; Woo LL; Potter BV; Reed MJ; Purohit A
Clin Cancer Res; 2006 Sep; 12(18):5543-9. PubMed ID: 17000691
[TBL] [Abstract][Full Text] [Related]
18. A new therapeutic strategy against hormone-dependent breast cancer: the preclinical development of a dual aromatase and sulfatase inhibitor.
Foster PA; Chander SK; Newman SP; Woo LW; Sutcliffe OB; Bubert C; Zhou D; Chen S; Potter BV; Reed MJ; Purohit A
Clin Cancer Res; 2008 Oct; 14(20):6469-77. PubMed ID: 18927286
[TBL] [Abstract][Full Text] [Related]
19. Steroid sulfatase expression is an independent predictor of recurrence in human breast cancer.
Utsumi T; Yoshimura N; Takeuchi S; Ando J; Maruta M; Maeda K; Harada N
Cancer Res; 1999 Jan; 59(2):377-81. PubMed ID: 9927050
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of steroid sulphatase activity via the percutaneous route: a new option for breast cancer therapy.
Purohit A; Chander SK; Woo LW; Parsons MF; Jhalli R; Potter BV; Reed MJ
Anticancer Res; 2008; 28(3A):1517-23. PubMed ID: 18630506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
